Effects of antiparkinsonian agents on β-amyloid and α-synuclein oligomer formation in vitro.

about

Phenolic compounds prevent the oligomerization of α-synuclein and reduce synaptic toxicity.Carriers of a common variant in the dopamine transporter gene have greater dementia risk, cognitive decline, and faster ventricular expansion.The Oligomer Hypothesis in α-Synucleinopathy.

P2860

Q35643171-5C5DB821-75DB-4563-A50D-A840174572D4 Q35733219-499608E2-A2EB-4821-89EC-D177B8E44749 Q47922790-2B32416C-2994-4575-A512-79F058946599

P2860

Effects of antiparkinsonian agents on β-amyloid and α-synuclein oligomer formation in vitro.

Item

http://www.wikidata.org/entity/Q47862181

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Effects of antiparkinsonian ag ...... n oligomer formation in vitro.

@en

Effects of antiparkinsonian ag ...... n oligomer formation in vitro.

@nl

type

Item

label

Effects of antiparkinsonian ag ...... n oligomer formation in vitro.

@en

Effects of antiparkinsonian ag ...... n oligomer formation in vitro.

@nl

prefLabel

Effects of antiparkinsonian ag ...... n oligomer formation in vitro.

@en

Effects of antiparkinsonian ag ...... n oligomer formation in vitro.

@nl

P1476

Effects of antiparkinsonian ag ...... n oligomer formation in vitro.

@en

P2093

Jun-Ichi Takasaki

http://www.w3.org/2001/XMLSchema#string

Kenjiro Ono

http://www.w3.org/2001/XMLSchema#string

Masahito Yamada

http://www.w3.org/2001/XMLSchema#string

Ryoichi Takahashi

http://www.w3.org/2001/XMLSchema#string

Tokuhei Ikeda

http://www.w3.org/2001/XMLSchema#string

P2860

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

Effects of grape seed-derived polyphenols on amyloid beta-protein self-assembly and cytotoxicity

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide

Formation of toxic oligomeric alpha-synuclein species in living cells

Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

Parkinson's disease

Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct.

Entacapone and tolcapone, two catechol O-methyltransferase inhibitors, block fibril formation of alpha-synuclein and beta-amyloid and protect against amyloid-induced toxicity

Chemistry for the analysis of protein-protein interactions: rapid and efficient cross-linking triggered by long wavelength light.

P304

1371-1381

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JNR.23256

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255178413

http://www.w3.org/2001/XMLSchema#string

P698

23913715

http://www.w3.org/2001/XMLSchema#string

P921

Synuclein

Effects of antiparkinsonian agents on β-amyloid and α-synuclein oligomer formation in vitro.

about

P2860

P2860

Effects of antiparkinsonian agents on β-amyloid and α-synuclein oligomer formation in vitro.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921